)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Sichuan Kelun Pharmaceutical
Sichuan Kelun Pharmaceutical (002422) investor relations material
Sichuan Kelun Pharmaceutical Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary29 Apr, 2026
Executive summary
Revenue for Q1 2026 was ¥4.26 billion, down 2.98% year-over-year.
Net profit attributable to shareholders was ¥453.7 million, a 22.34% decrease year-over-year.
Cash flow from operating activities dropped 44.45% year-over-year to ¥249.6 million.
Significant R&D investments and new product developments were highlighted.
Financial highlights
Operating income: ¥4.26 billion, down from ¥4.39 billion year-over-year.
Net profit: ¥453.7 million, down from ¥584.2 million year-over-year.
Basic and diluted EPS: ¥0.29, down from ¥0.37 year-over-year.
Total assets at quarter-end: ¥41.14 billion, up 3.28% from year-end 2025.
Owner's equity: ¥24.64 billion, up 1.71% from year-end 2025.
Outlook and guidance
Multiple new drug clinical trials and product approvals signal ongoing innovation.
Continued focus on R&D and product pipeline expansion.
Source of the 9362% surge in non-operating income
R&D impact on the 44.45% operating cash flow drop
Reason for the 127.86% drop in income tax expense
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sichuan Kelun Pharmaceutical
- 2025 revenue rose 6.5% to RMB 2.06B, with robust R&D and commercialization expansion.002422
H2 202517 Apr 2026 - ADC innovation and global partnerships drive growth, with multiple approvals and expanding indications.00242244th Annual J.P. Morgan Healthcare Conference10 Apr 2026
- Net profit up 28.24% on 9.52% revenue growth, with improved cost and product mix.002422H1 202417 Feb 2026
- Revenue and profit fell sharply, but first-year commercialization and R&D remain strong.002422H1 202517 Feb 2026
- Net profit surged 19.53% to ¥2.94 billion on record revenue and strong innovation output.002422H2 202412 Dec 2025
- Q3 profit and revenue dropped significantly, but new drug approvals and financing boost outlook.002422Q3 202531 Oct 2025
- Net profit surged 19.88% in Q3 2024, driven by innovation and capital optimization.002422Q3 202413 Jun 2025
- Revenue and profit fell sharply in Q1 2025, but new drug approvals advanced pipeline.002422Q1 20256 Jun 2025
Next Sichuan Kelun Pharmaceutical earnings date
Q2 202618 Aug, 2026
Sichuan Kelun Pharmaceutical
Next Sichuan Kelun Pharmaceutical earnings date
Q2 202618 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage